These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3477567)

  • 21. AIDS studies in Japan.
    Harada S; Yamamoto N
    Jpn J Cancer Res; 1987 May; 78(5):415-27. PubMed ID: 3112053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization test for BK virus: plaque reduction detected by immunoperoxidase staining.
    Flaegstad T; Traavik T; Christie KE; Joergensen J
    J Med Virol; 1986 Jul; 19(3):287-96. PubMed ID: 3016170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel cytopathic microtitre plate assay for hepatitis A virus and anti-hepatitis A neutralizing antibodies.
    Beales LP; Wood DJ; Minor PD; Saldanha JA
    J Virol Methods; 1996 May; 59(1-2):147-54. PubMed ID: 8793842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to human immunodeficiency virus (HTLV-III/LAV) in people from Lagos and Cross River States of Nigeria.
    Okpara RA; Akinsete I; Williams EE; Schneider J; Wendler I; Hunsmann G
    Acta Haematol; 1988; 79(2):91-3. PubMed ID: 3124480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia.
    Robert-Guroff M; Giardina PJ; Robey WG; Jennings AM; Naugle CJ; Akbar AN; Grady RW; Hilgartner MW
    J Immunol; 1987 Jun; 138(11):3731-6. PubMed ID: 3495568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme immunoassays for the demonstration of antibodies to HIV-2SBL-6669 and HTLV-IV (SIVmac).
    Biberfeld G; Thorstensson R; Bergström M; Naucler A; Costa CM
    AIDS; 1988 Jun; 2(3):195-9. PubMed ID: 3134913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells.
    Schmidt NJ; Dennis J; Lennette EH
    J Clin Microbiol; 1976 Jul; 4(1):61-6. PubMed ID: 182716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new cell line-based neutralization assay for primary HIV type 1 isolates.
    Shi Y; Albert J; Francis G; Holmes H; Fenyö EM
    AIDS Res Hum Retroviruses; 2002 Sep; 18(13):957-67. PubMed ID: 12230938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LAV/HTLV-III antibodies in patients treated with intravenous gammaglobulins.
    Kanoh T; Ohno T; Funakoshi N; Fujii H; Okada T
    Tohoku J Exp Med; 1986 Nov; 150(3):361-2. PubMed ID: 2435020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Karpas HIV cell test to detect antibodies to HIV-2.
    Karpas A; Hayhoe FG; Hill F; Anderson M; Tenant-Flower M; Howard L; Oates JK
    Lancet; 1987 Jul; 2(8551):132-3. PubMed ID: 2439855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel agglutination test for the human immunodeficiency virus antibody: a comparative study with enzyme-linked immunosorbent assay and immunofluorescence.
    Yoshida T; Matsui T; Kobayashi S; Harada S; Kurimura T; Hinuma Y; Yamamoto N
    Jpn J Cancer Res; 1986 Dec; 77(12):1211-3. PubMed ID: 3102425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microneutralization test in PK(15) cells for assay of antibodies to louping ill virus.
    Timoney PJ; Geraghty VP; Harrington AM; Dillon PB
    J Clin Microbiol; 1984 Jul; 20(1):128-30. PubMed ID: 6086707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity and sensitivity of anti-HTLV-III/LAV determinations with a recombinant antigen competitive ELISA.
    Habermehl KO; Zorr B; Deinhardt F; Gürtler L; Koch MA; Maass G; Höpken W; Knocke KW
    Infection; 1986; 14(5):216. PubMed ID: 3539813
    [No Abstract]   [Full Text] [Related]  

  • 34. Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein.
    Chiodi F; von Gegerfeldt A; Albert J; Fenyö EM; Gaines H; von Sydow M; Biberfeld G; Parks E; Norrby E
    J Med Virol; 1987 Sep; 23(1):1-9. PubMed ID: 3500271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New developments in ELISA verification of anti-HIV screening of blood donors.
    Hellings JA; Theunissen H; Keur W; Siebelink-Liauw A
    J Virol Methods; 1987 Aug; 17(1-2):11-7. PubMed ID: 3478345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a new neutralization test for measles virus.
    Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
    J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
    Heinz FX; Kunz C; Barrett N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralizing monoclonal antibodies to the AIDS virus.
    Thomas EK; Weber JN; McClure J; Clapham PR; Singhal MC; Shriver MK; Weiss RA
    AIDS; 1988 Feb; 2(1):25-9. PubMed ID: 2451922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralizing antibody to the AIDS virus. Prevalence, clinical significance and virus strain specificity.
    Prince AM; Pascual D; Bardina-Kosolopov L; Kurokawa D; Baker L; Rubinstein P
    Antibiot Chemother (1971); 1987; 38():151-8. PubMed ID: 2444154
    [No Abstract]   [Full Text] [Related]  

  • 40. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.